Parexel International Corporation - Swot Analysis-Aarkstore Enterprise

PAREXEL International Corporation - SWOT Analysismillion during FY2009, a decrease of 12.7% over
company profile is the essential source for top-levelFY2008. The net profit was $39.3 million in FY2009, a
company data and information. PAREXEL Internationaldecrease of 39.2% over FY2008.
Corporation - SWOT Analysis examines theScope of the Report
company's key business structure and operations,- Provides all the crucial information on PAREXEL
history and products, and provides summary analysisInternational Corporation required for business and
of its key revenue lines and strategy.competitor intelligence needs
PAREXEL International (PAREXEL) is a- Contains a study of the major internal and external
biopharmaceutical services company that providesfactors affecting PAREXEL International Corporation
expertise in clinical research, medical communicationsin the form of a SWOT analysis as well as a
services, consulting, and informatics, and advancedbreakdown and examination of leading product
technology products and services to therevenue streams of PAREXEL International
pharmaceutical, biotechnology, and medical deviceCorporation
industries. The company operates globally in the-Data is supplemented with details on PAREXEL
Americas, Europe, Asia Pacific, Middle East and Africa.International Corporation history, key executives,
It is headquartered at Waltham, Massachusetts andbusiness description, locations and subsidiaries as well
employed 9,275 people as of June 2009. Theas a list of products and services and the latest
company recorded revenues of $1,246.9 million duringavailable statement from PAREXEL International
the financial year (FY) ended June 2009, an increaseCorporation
of 7.2% over FY2008. The increase in revenues wasFor more information please visit:
due to strong demand for clinical research services.PH.NO.
The operating profit of the company was $75.6